| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_864f1114034e328bbc316311613a2fba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbba684444c2a761ae8f3319bd7c5202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a33927dc8e7dd69e81c0cfc706fec78 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 |
| filingDate |
2012-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3044754cb367112c58ba29b2f16c017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd581f2ece2e5cac44bba5ee5835883f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec49158583718f7b18b66c3268cff84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60157c8b0bf2f8c66841c1b55aea05c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ab0f16e6306cab5588f6391ab20cfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf48aa818bac5883f17ed57dc7409763 |
| publicationDate |
2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2784086-A1 |
| titleOfInvention |
Stem-cell engineering and the therapeutic use thereof |
| abstract |
The present invention relates to mesenchymal stem cells (MSC) genetically modified to express sST2 or parts thereof for use in the treatment of airway immune inflammatory and lung diseases, wherein said mesenchymal stem cells are not human embryonic stem cells. The present invention also relates to pharmaceutical compositions comprising said mesenchymal stem cells. |
| priorityDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |